Assembly Biosciences Inc
ASMB18.385USD
-0.015-0.08%
交易中 （美東）報價延遲15分鐘
140.07M總市值
虧損本益比TTM
關於 Assembly Biosciences Inc 公司
Assembly Biosciences, Inc. 是一家生物技術公司，致力於開發小分子抗病毒療法。該公司的產品線包括兩種針對複發性生殖器皰疹的解旋酶-引發酶抑制劑 (HPI)、一種口服生物可利用的丁型肝炎病毒 (HDV) 進入抑制劑、一種臨牀階段的衣殼組裝調節劑 (CAM)，旨在在幾個關鍵點破壞乙型肝炎病毒 (HBV) 的複製週期，以實現有限治療和功能性治癒，以及專注於發現治療毀滅性病毒性疾病的療法的研究項目，包括一種針對移植相關皰疹病毒的非核苷聚合酶抑制劑 (NNPI) 和一種針對 HBV 和 HDV 的小分子干擾素-α (IFN-α) 受體 (IFNAR) 激動劑。HPI 是針對 HSV-1 和 HSV-2 的抗病毒藥物，具有經過臨牀驗證的作用機制。其 HBV、HSV-1 和 HSV-2 項目包括 ABI-6250、ABI-5366 和 ABI-1179。
公司簡介
公司代碼ASMB
公司名稱Assembly Biosciences Inc
上市日期Dec 17, 2010
CEO- -
員工數量73
證券類型Ordinary Share
年結日Dec 17
公司地址Two Tower Place
城市SOUTH SAN FRANCISCO
上市交易所NASDAQ Global Select Consolidated
國家United States of America
郵編94080
電話18334094583
網址https://www.assemblybio.com/
公司代碼ASMB
上市日期Dec 17, 2010
CEO- -
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Dr. John G. McHutchison, M.D.
Dr. John G. McHutchison, M.D.
Director
Director
16.60K
+18.30%
Mr. Jason A. Okazaki
Mr. Jason A. Okazaki
President, Principal Executive Officer, Director
President, Principal Executive Officer, Director
14.11K
+55.95%
Dr. Nicole S. White, Ph.D.
Dr. Nicole S. White, Ph.D.
Chief Manufacturing Officer
Chief Manufacturing Officer
7.82K
+78.83%
Sir Michael Houghton, Esq.
Sir Michael Houghton, Esq.
Independent Director
Independent Director
3.20K
--
Mr. Anthony E. (Tony) Altig
Mr. Anthony E. (Tony) Altig
Independent Director
Independent Director
666.00
--
Ms. Jeanette Bjorkquist
Ms. Jeanette Bjorkquist
Principal Financial Officer, Principal Accounting Officer
Principal Financial Officer, Principal Accounting Officer
--
--
Ms. Gina Consylman, CPA
Ms. Gina Consylman, CPA
Independent Director
Independent Director
--
--
Dr. Tomas Cihlar, Ph.D.
Dr. Tomas Cihlar, Ph.D.
Director
Director
--
--
Mr. Robert D. Cook, II
Mr. Robert D. Cook, II
Director
Director
--
--
Dr. William E. Delaney, IV, Ph.D.
Dr. William E. Delaney, IV, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. John G. McHutchison, M.D.
Dr. John G. McHutchison, M.D.
Director
Director
16.60K
+18.30%
Mr. Jason A. Okazaki
Mr. Jason A. Okazaki
President, Principal Executive Officer, Director
President, Principal Executive Officer, Director
14.11K
+55.95%
Dr. Nicole S. White, Ph.D.
Dr. Nicole S. White, Ph.D.
Chief Manufacturing Officer
Chief Manufacturing Officer
7.82K
+78.83%
Sir Michael Houghton, Esq.
Sir Michael Houghton, Esq.
Independent Director
Independent Director
3.20K
--
Mr. Anthony E. (Tony) Altig
Mr. Anthony E. (Tony) Altig
Independent Director
Independent Director
666.00
--
Ms. Jeanette Bjorkquist
Ms. Jeanette Bjorkquist
Principal Financial Officer, Principal Accounting Officer
Principal Financial Officer, Principal Accounting Officer
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 6月14日 週六
更新時間: 6月14日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Gilead Sciences Inc
28.93%
Schornstein (Alexander)
9.53%
The Vanguard Group, Inc.
2.83%
B Group, Inc.
2.62%
Renaissance Technologies LLC
1.48%
Other
54.61%
持股股東
持股股東
佔比
Gilead Sciences Inc
28.93%
Schornstein (Alexander)
9.53%
The Vanguard Group, Inc.
2.83%
B Group, Inc.
2.62%
Renaissance Technologies LLC
1.48%
Other
54.61%
股東類型
持股股東
佔比
Corporation
28.93%
Individual Investor
10.37%
Investment Advisor
7.95%
Investment Advisor/Hedge Fund
2.83%
Hedge Fund
2.16%
Research Firm
0.04%
Pension Fund
0.03%
Other
47.69%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
95
4.00M
52.31%
-445.87K
2025Q1
96
3.96M
52.03%
-545.18K
2024Q4
98
3.98M
62.54%
+317.06K
2024Q3
100
3.09M
48.81%
-530.17K
2024Q2
100
3.18M
50.27%
+64.71K
2024Q1
106
2.47M
41.54%
+268.64K
2023Q4
118
2.50M
200.35%
+260.11K
2023Q3
132
888.05K
20.29%
-1.13M
2023Q2
155
960.87K
22.02%
-1.33M
2023Q1
204
1.08M
24.92%
-1.35M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Gilead Sciences Inc
2.21M
28.93%
--
--
Mar 31, 2025
Schornstein (Alexander)
728.11K
9.53%
-44.00K
-5.70%
Dec 19, 2024
The Vanguard Group, Inc.
215.98K
2.83%
+15.53K
+7.74%
Mar 31, 2025
B Group, Inc.
200.00K
2.62%
+149.35K
+294.86%
Mar 31, 2025
Renaissance Technologies LLC
113.31K
1.48%
+18.60K
+19.64%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
71.97K
0.94%
-484.00
-0.67%
Mar 31, 2025
Geode Capital Management, L.L.C.
47.70K
0.62%
+1.07K
+2.29%
Mar 31, 2025
Monimus Capital Management, LP
42.07K
0.55%
--
--
Mar 31, 2025
Northern Trust Investments, Inc.
28.32K
0.37%
-326.00
-1.14%
Mar 31, 2025
Federated MDTA LLC
25.39K
0.33%
--
--
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0.02%
Fidelity Enhanced Small Cap ETF
0%
Avantis US Small Cap Value ETF
0%
Dimensional US Core Equity 1 ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Micro-Cap ETF
佔比0.02%
Fidelity Enhanced Small Cap ETF
佔比0%
Avantis US Small Cap Value ETF
佔比0%
Dimensional US Core Equity 1 ETF
佔比0%
Avantis US Small Cap Equity ETF
佔比0%
iShares Core S&P Total U.S. Stock Market ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Feb 08, 2024
Merger
12<1
Feb 08, 2024
Merger
12<1
Feb 08, 2024
Merger
12<1
Feb 08, 2024
Merger
12<1
公告日期
類型
比率
Feb 08, 2024
Merger
12<1
Feb 08, 2024
Merger
12<1
Feb 08, 2024
Merger
12<1
Feb 08, 2024
Merger
12<1
